WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 23-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 13'4701 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 24'4981 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 9'855  9'890  9'925  9'958  9'989  10'224  10'385  10'759 
Births 92  92  93  94  94  96  126  153 
Surviving infants 92  92  93  93  94  95  124  150 
Pop. less than 5 years 463  469  476  483  488  494  615  877 
Pop. less than 15 years 1'435  1'438  1'443  1'449  1'456  1'719  2'117  2'366 
Female 15-49 years 2'325  2'340  2'351  2'361  2'371  2'560  2'533  2'577 

Number of reported cases

(Click for retrospective incidence data for Hungary)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  29  1'198 
Mumps
ChartChart
  223 
Pertussis
ChartChart
  20  20  12  22 
Polio*
ChartChart
 
Rubella
ChartChart
  107 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10  25  48 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Hungary)
Vaccine year result method % card seen                                                
BCG          99*  99*  99*  99*  99*  99*  99  99 
DTP1          99*  99*  99*  99*  99*  99* 
DTP3          99*  99*  99*  99*  99*  99*  99  99 
DTP4          99  99* 
IPV1          99*  99* 
HepB_BD         
HepB3         
Hib3          99*  99*  99*  99*  99*  99* 
JapEnc         
MCV1          99*  99*  99*  99*  99*  99*  99  99 
MCV2          99*  99*  99  99  99*  99* 
PCV1          98  96  95  93 
PCV3          91  93  92  90  84 
Pol3          99*  99*  99*  99*  99*  99*  99  98 
Rota1         
RotaC         
Rubella1          99*  99*  99*  99*  99* 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Hungary)
BCG
ChartChart
  99  99  99  99  99  99  99 
DTP1
ChartChart
  99  99  99  99  99  99  99 
DTP3
ChartChart
  99  99  99  99  99  99  99 
HepB3
ChartChart
 
HepB_BD
ChartChart
 
Hib3
ChartChart
  99  99  99  99  99 
MCV1
ChartChart
  99  99  99  99  99  99  99 
MCV2
ChartChart
  99  99  99  99  99 
PCV3
ChartChart
  93  92  90  84 
Pol3
ChartChart
  99  99  99  99  99  99  98 
RotaC
ChartChart
 

Number of districts in the country 80  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibIPV 2, 3, 4, 18 months; Yes or 2, 4, 6, 21 months;
DTaPIPV 6 years; Yes
HPV 12 years (x2); Yes
HepB 12 years (x2); Yes
Influenza_Adult >= 60 years; Yes Pregnant women, health care workers, chronic diseases, and any other risk group
Influenza_Pediatric Yes children with chronic diseases
MMR 15 months; 11 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Tdap 11 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2020  2013-2020  2010-2015  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number   82  81 

System performance

Total Nº districts in country number 80  81  81  81  81  81  81 
Nº districts with DTP3 coverage >=80% number 80    81  81  81  81  81 
% of districts with DTP3 coverage >=80% From 0 to 100% 100    100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 80    81  81  81  81  81 
% of districts with MCV1 coverage >=95% From 0 to 100% 100    100  100  100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100        100  98  98 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.